Jiangxi Wohua Jishun Pharmaceutical

Jiangxi Wohua Jishun Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceuticals. As a wholly-owned subsidiary of Shandong Wohua Pharmaceutical Technology, the company focuses primarily on cardiovascular and cerebrovascular health. Its flagship product, Hedan Tablet, is a prominent TCM treatment for hyperlipidemia and atherosclerosis in the Chinese market. The company operates large-scale, GMP-certified manufacturing facilities in Jiangxi Province and maintains a robust portfolio of natural medicine solutions. Wohua Jishun plays a critical role in the parent company's integrated strategy for chronic disease management.